GLOBAL BLOOD THERAPEUTICS IN's ticker is GBT and the CUSIP is 37890U108. A total of 198 filers reported holding GLOBAL BLOOD THERAPEUTICS IN in Q2 2021. The put-call ratio across all filers is 0.17 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $4,581,000 | -61.6% | 179,806 | -47.2% | 0.04% | -58.6% |
| Q2 2021 | $11,922,000 | -67.0% | 340,432 | -61.6% | 0.09% | -68.1% |
| Q1 2021 | $36,117,000 | +520.5% | 886,300 | +861.3% | 0.27% | +425.0% |
| Q2 2020 | $5,821,000 | +115.5% | 92,201 | +74.4% | 0.05% | +73.3% |
| Q1 2020 | $2,701,000 | -74.6% | 52,859 | -60.6% | 0.03% | -62.0% |
| Q4 2019 | $10,652,000 | +258.8% | 134,000 | +119.0% | 0.08% | +243.5% |
| Q3 2019 | $2,969,000 | -10.8% | 61,184 | -3.3% | 0.02% | -8.0% |
| Q2 2019 | $3,328,000 | -64.1% | 63,268 | -67.0% | 0.02% | -62.7% |
| Q1 2018 | $9,268,000 | – | 191,890 | – | 0.07% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Alerce Investment Management, L.P. | 356,270 | $24,262,000 | 23.36% |
| Twin Securities, Inc. | 376,669 | $25,651,000 | 11.94% |
| Paradigm Biocapital Advisors LP | 1,175,879 | $80,077,000 | 10.68% |
| Chicago Capital Management, LLC | 246,246 | $16,769,000 | 9.12% |
| HARVEST MANAGEMENT LLC | 141,500 | $9,636,000 | 7.78% |
| Fernwood Investment Management, LLC | 174,724 | $11,899,000 | 5.02% |
| ArchPoint Investors | 168,725 | $11,490,000 | 4.69% |
| HAVENS ADVISORS LLC | 46,000 | $3,133,000 | 4.69% |
| Perceptive Advisors | 2,322,247 | $158,145,000 | 4.59% |
| Crabel Capital Management, LLC | 112,680 | $7,674,000 | 4.48% |